Lupin Limited has informed the Exchange regarding a press release dated December 05, 2025, titled "Lupin Receives Tentative Approval from U.S. FDA for Siponimod Tablets".
Lupin Limited has informed the Exchange regarding a press release dated December 05, 2025, titled "Lupin Receives Tentative Approval from U.S. FDA for Siponimod Tablets".